RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Bought some moreSkater wrote: I like your optimism, but they did $10M in q2, unless they are different than the others, it'd be pretty surprising for them to hit $30m (300% increase) or $40M in Q4 (400% increase). Time will tell. I expect there will be a lot of pain in the industry this year, Corona aside. Hexo on the ropes (see the news this morning), ACB needs a partner or injection soon. I don't see anyone stepping up to throw dollars at consolidation yet. No one needs capacity. they all need sales. What is that worth? Good luck.
Guess what happens when HEXO falls off the map and others such as ACB. Someone else takes their share of the market. A few giants falling will be majorly beneficial to those that remain.
Hypotheticlaly speaking if HEXO and ACB both went bankrupt, that creates a $100M per quarter void in the supply. Someone has to step in and fill that gap.